IL108698A0 - Novel polypeptides, nucleic acids encoding them and their use - Google Patents

Novel polypeptides, nucleic acids encoding them and their use

Info

Publication number
IL108698A0
IL108698A0 IL10869894A IL10869894A IL108698A0 IL 108698 A0 IL108698 A0 IL 108698A0 IL 10869894 A IL10869894 A IL 10869894A IL 10869894 A IL10869894 A IL 10869894A IL 108698 A0 IL108698 A0 IL 108698A0
Authority
IL
Israel
Prior art keywords
bssl
nucleic acids
acids encoding
novel polypeptides
variant
Prior art date
Application number
IL10869894A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9300686A external-priority patent/SE9300686D0/xx
Priority claimed from SE9300722A external-priority patent/SE9300722D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL108698A0 publication Critical patent/IL108698A0/xx
Priority to IL14401501A priority Critical patent/IL144015A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
IL10869894A 1993-03-01 1994-02-17 Novel polypeptides, nucleic acids encoding them and their use IL108698A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL14401501A IL144015A0 (en) 1993-03-01 2001-06-26 Transgenic non-human mammals producing bssl variants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300686A SE9300686D0 (sv) 1993-03-01 1993-03-01 Novel polypeptides
SE9300722A SE9300722D0 (sv) 1993-03-04 1993-03-04 Novel polypeptides ii

Publications (1)

Publication Number Publication Date
IL108698A0 true IL108698A0 (en) 1994-05-30

Family

ID=26661673

Family Applications (2)

Application Number Title Priority Date Filing Date
IL10869894A IL108698A0 (en) 1993-03-01 1994-02-17 Novel polypeptides, nucleic acids encoding them and their use
IL144015A IL144015A (en) 1993-03-01 1994-02-17 Nonhuman transgenic mammals producing BSSL variants

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144015A IL144015A (en) 1993-03-01 1994-02-17 Nonhuman transgenic mammals producing BSSL variants

Country Status (28)

Country Link
US (2) US5827683A (uk)
EP (1) EP0687296B1 (uk)
JP (1) JP3837444B2 (uk)
KR (2) KR100312825B1 (uk)
CN (2) CN1071790C (uk)
AT (1) ATE317429T1 (uk)
AU (1) AU675701B2 (uk)
BR (1) BR9406376A (uk)
CA (1) CA2156083C (uk)
CZ (1) CZ290927B6 (uk)
DE (1) DE69434622T2 (uk)
DK (1) DK0687296T3 (uk)
EE (1) EE9400458A (uk)
ES (1) ES2258262T3 (uk)
FI (1) FI954082A0 (uk)
HU (1) HU221119B1 (uk)
IL (2) IL108698A0 (uk)
IS (1) IS4130A (uk)
NO (1) NO953426L (uk)
NZ (1) NZ262529A (uk)
PL (1) PL184960B1 (uk)
PT (1) PT687296E (uk)
RU (1) RU2219239C2 (uk)
SG (1) SG52597A1 (uk)
SK (1) SK285420B6 (uk)
TW (1) TW387013B (uk)
UA (1) UA48109C2 (uk)
WO (1) WO1994020610A1 (uk)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
JP3007161B2 (ja) * 1994-12-01 2000-02-07 オクラホマ メディカル リサーチ ファウンデーション コレステロール吸収を減少するための方法および組成物
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
SE9501939D0 (sv) * 1995-05-24 1995-05-24 Astra Ab DNA molecules for expression of polypeptides
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
SE9801424D0 (sv) 1998-04-22 1998-04-22 Astra Ab Expression methods
WO2001081366A2 (en) * 2000-04-21 2001-11-01 Monsanto Technology Llc Purification of ace inhibiting polypeptides containing vpp from milk
FR2868424B1 (fr) * 2004-03-31 2008-04-11 Univ Aix Marseille Ii Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique
CA2558754C (fr) 2004-03-31 2015-09-22 Universite De La Mediterranee Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique
CN100343391C (zh) * 2004-12-31 2007-10-17 中国农业大学 卵巢注射法制备转基因动物
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
JP5850940B2 (ja) * 2010-10-21 2016-02-03 スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ ヒト乳児の発育速度を増大させる方法
RU2013123056A (ru) 2010-10-21 2014-11-27 Сведиш Орфан Биовитрум Аб (Пабл) Способ повышения всасывания ненасыщенных жирных кислот у грудных детей
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
MX2013013224A (es) * 2011-05-18 2014-04-25 Swedish Orphan Biovitrum Ab Publ Procedimiento de purificacion de proteinas de bajo ph.
CN103088000A (zh) * 2012-03-23 2013-05-08 北京济福霖生物技术有限公司 在哺乳动物乳腺中过表达胆盐激活脂酶的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
SE9001985D0 (sv) * 1990-06-01 1990-06-01 Astra Ab New chemical products

Also Published As

Publication number Publication date
CZ216995A3 (en) 1997-05-14
AU6223794A (en) 1994-09-26
NO953426D0 (no) 1995-08-31
CN1187450C (zh) 2005-02-02
JP3837444B2 (ja) 2006-10-25
CA2156083C (en) 2008-07-15
CA2156083A1 (en) 1994-09-15
SK285420B6 (sk) 2007-01-04
KR100312825B1 (ko) 2001-12-28
PL310413A1 (en) 1995-12-11
US5827683A (en) 1998-10-27
IL144015A (en) 2006-08-20
KR100357016B1 (ko) 2002-10-19
HU221119B1 (en) 2002-08-28
HU9502561D0 (en) 1995-10-30
NO953426L (no) 1995-08-31
WO1994020610A1 (en) 1994-09-15
PT687296E (pt) 2006-05-31
SK108595A3 (en) 1997-01-08
EP0687296B1 (en) 2006-02-08
UA48109C2 (uk) 2002-08-15
CN1346888A (zh) 2002-05-01
NZ262529A (en) 1997-07-27
BR9406376A (pt) 1996-01-16
JPH08507439A (ja) 1996-08-13
ES2258262T3 (es) 2006-08-16
RU2219239C2 (ru) 2003-12-20
CN1071790C (zh) 2001-09-26
CZ290927B6 (cs) 2002-11-13
TW387013B (en) 2000-04-11
PL184960B1 (pl) 2003-01-31
AU675701B2 (en) 1997-02-13
FI954082A (fi) 1995-08-31
FI954082A0 (fi) 1995-08-31
DK0687296T3 (da) 2006-06-12
CN1121355A (zh) 1996-04-24
HUT73398A (en) 1996-07-29
ATE317429T1 (de) 2006-02-15
IS4130A (is) 1994-09-02
EP0687296A1 (en) 1995-12-20
DE69434622D1 (de) 2006-04-20
EE9400458A (et) 1996-06-17
SG52597A1 (en) 1998-09-28
US5763739A (en) 1998-06-09
DE69434622T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
IL108698A0 (en) Novel polypeptides, nucleic acids encoding them and their use
AU7957898A (en) Nucleic acids encoding polypeptide having protease activity
ATE317904T1 (de) Überexpression von phytase in hefesystemen
EP0379556A4 (en) Production of glucose oxidase in recombinant systems
AU3907889A (en) Dna sequences encoding polypeptides having beta-1, 3-glucanase activity
HU9503618D0 (en) Recombinant stratum corneum chymotryptic enzyme (scce)
AU3498189A (en) Fibronectin binding protein
HUP9900323A2 (hu) Bakteriofág endoszialidáz aktivitással rendelkező rekombináns fehérje
IL98273A0 (en) Dna sequences,proteins having esterase activity coded by them,and use of such proteins
HU9601232D0 (en) Tomato xyloglucan endo-transglicosylase
CA2253006A1 (en) .beta.-carotene hydroxylase gene
ATE380245T1 (de) Gen von alteromonas
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
DE69631127D1 (en) Glykosyltransferase expression in aspergillus
AU2191788A (en) Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetase from aspergillus nidulans
IL70662A (en) Recombinant dna expression vectors useful in bacillus and e.coli host cells
EP0570075A3 (en) Cloning and expression of DNA encoding a ripening form of a polypeptide having rhamnogalacturonase activity.
CA2067334A1 (en) Recombinant production of lactoperoxidase
EP0199769A4 (en) NEW POLYPEPTIDES WITH GROWTH FACTOR EFFECT AND THESE ENCODING NUCLEIC ACID SEQUENCES.
ZA91752B (en) Process for the enzymatic cleavage or recombinant proteins using iga proteases
AU2163588A (en) Stabilization of enzymes by inhibiting proteolytic enzyme contaminants
IE820987L (en) Esters of n-substituted amino acids
WO2002077220A3 (en) Nucleic acids encoding human est1 proteins
ZA905516B (en) Recombinant gene coding for a protein such as urate oxidase
ATE75255T1 (de) Peptid und dafuer kodierendes gen.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired